REGENXBIO Inc. Profile Avatar - Palmy Investing

REGENXBIO Inc.

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact…

Biotechnology
US, Rockville [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of RGNX's Analysis
CIK: 1590877 CUSIP: 75901B107 ISIN: US75901B1070 LEI: - UEI: -
Secondary Listings
RGNX has no secondary listings inside our databases.